
Nature Medicine Study Links Early Pregnancy Protein to Preeclampsia Risk
Nature Medicine study suggests early-pregnancy ISM2 levels may help predict preeclampsia and fetal growth restriction.
Studies on new and existing drugs and treatments, from early discovery to real-world results.

Nature Medicine study suggests early-pregnancy ISM2 levels may help predict preeclampsia and fetal growth restriction.

UK medical research advances as new studies and funding signal progress toward better patient care and NHS impact.

New mouse research suggests GLP-1 drugs may influence ageing, raising fresh questions for medical research.

Early trial data suggest a targeted multiple sclerosis therapy may retrain immunity without broadly suppressing the immune system.

BMJ study finds patient-centred digital adherence technology improved tuberculosis treatment outcomes in a pragmatic trial.

Early NHS psilocybin therapy trial shows promise for treatment-resistant depression, but larger studies are still needed.

Nature Medicine reports a 38,753-patient analysis on heart-failure therapy effects on blood pressure, kidney function and potassium.

Nature Medicine reports a prospective emergency department AI study, advancing clinical decision support research in medicine.
Nature Medicine reports a pilot AI decision-support tool was safe in emergency care, but clinician use declined over four weeks.

Single-cell research reveals why some CAR-T therapies work better, offering new clues for more precise cancer treatment.